CALC
NASD CalciMedica, Inc.$1.27 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.27, $0.07 below the day’s high of $1.34
- YTD change
- -96.15%
- vs 20-day SMA
- -27.03%
- vs 200-day SMA
- -79.83%
Price ranges
Price & Performance
+0.62 (+95.08%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.0% away from all-time highs of $42.95
- CALC is down 96% since the beginning of the year
- CALC is down 92% over the past 12 months
- CALC is down 40% over the past 1 month
- 4% of all CALC investors are betting against CALC
CALC reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -62.4%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- -23.03%
- vs 8-day SMA
- -17.33%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.